Incoming ProBiotix Health CEO Steen Anderson and OptiBiotix Group CEO Stephen O’Hara speak to Proactive about how ProBiotix performed in 2022, before looking ahead to what investors can expect from the coming year.
Anderson explains what it was that attracted to him to the CEO role at ProBiotix, and O’Hara reveals the “big commercial opportunities” he expects to come ProBiotix’s way in 2023.
ProBiotix Health PLC is an OptiBiotix Health PLC subsidiary.
#ProactiveInvestors #ProBiotix #OptiBiotix #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews #biotech
source